Suchergebnisse - "Pavilack, Melissa"

PubPharm (7)

1

Real-world disease burden and outcomes of brain metastases in EGFR mutation-positive non-small-cell lung cancer

enthalten in: Future oncology (London, England) | 2020

von Nadler, E. | Espirito, J. | Pavilack, M. | +2

2

Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors

enthalten in: Advances in therapy | 2020

von Nadler, E. | Pavilack, M. | Espirito, J. | +2

3

Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancer

enthalten in: Future oncology (London, England) | 2019

von Bridges, J. | la Cruz, M. | Pavilack, M. | +4

4

Real-world treatment patterns among patients with unresected stage III non-small-cell lung cancer

enthalten in: Future oncology (London, England) | 2019

von Ryan, K. | Skinner, K. | Fernandes, A. | +4

5

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

enthalten in: Medical oncology (Northwood, London, England) | 2019

von Ryan, K. | Skinner, K. | Fernandes, A. | +4

6

Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer Patients Treated in the Community Practice Setting

enthalten in: Clinical lung cancer | 2018

von Nadler, E. | Espirito, J. | Pavilack, M. | +3

7

Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy : a real-world observational study

enthalten in: Journal of medical economics | 2018

von Skinner, K. | Fernandes, A. | Walker, M. | +2

1
[1]